ArticleFrontiers in immunology2022

Basiliximab for the therapy of acute T cell-mediated rejection in kidney transplant recipient with BK virus infection: A case report.

Tingting Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.